Long-Term Liabilities: The sum of all non-current liabilities.
Intellia Therapeutics, Inc. (NTLA) had Long-Term Liabilities of $61.40M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$15.05M |
|
$-96.23M |
|
-- |
|
$15.05M |
|
$115.58M |
|
$-100.53M |
|
$4.30M |
|
$-96.23M |
|
$-96.23M |
|
$-96.23M |
|
$-96.23M |
|
$-96.23M |
|
$-96.23M |
|
$-100.53M |
|
$-98.33M |
|
118.49M |
|
118.49M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$466.45M |
|
$15.52M |
|
$292.33M |
|
$758.78M |
|
$76.44M |
|
-- |
|
|
Long-Term Liabilities |
$61.40M |
$137.84M |
|
$620.94M |
|
$620.94M |
|
$620.94M |
|
120.45M |
|
| Cash Flow Statement Financials | |
$-117.35M |
|
$66.31M |
|
$33.57M |
|
$167.57M |
|
$150.10M |
|
$-17.47M |
|
$13.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-668.08% |
|
-668.08% |
|
-- |
|
-639.49% |
|
-639.49% |
|
$-117.42M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.65 |
|
54.61 |
|
-15.50% |
|
-15.50% |
|
-12.68% |
|
-15.50% |
|
$5.16 |
|
$-0.99 |
|
$-0.99 |
|